CST3 and COVID-19: Compared with the pre-pandemic period, during the COVID-19 pandemic, women had an increased risk of death associated with obesity, angina, elevated cystatin C levels, and a history of COVID-19, while men had an increased risk of death associated with asthma, elevated biomarkers of cardiovascular risk.